Hypoglycemia - 26/11/13
Doi : 10.1016/j.ecl.2013.07.002
Mazen Alsahli, MD a, b, John E. Gerich, MD c, ⁎ 
a Division of Endocrinology, Department of Medicine, Southlake Regional Health Center, 309-531 Davis Drive, Newmarket, Ontario L3Y 6P5, Canada
b Faculty of Medicine, Department of Medicine, University of Toronto, 1 King's College Cir, Toronto, Ontario M5S 1A8, Canada
c Division of Endocrinology, Department of Medicine, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, NY 14642, USA
∗Corresponding author. 403 Woodcrest Road, Wayne, PA 19087.
Résumé |
Hypoglycemia remains a common problem for patients with diabetes and is associated with substantial morbidity and mortality. This article summarizes our current knowledge of the epidemiology, pathogenesis, risk factors, and complications of hypoglycemia in patients with diabetes and discusses prevention and treatment strategies.
Le texte complet de cet article est disponible en PDF.Keywords : Type 1 diabetes, Type 2 diabetes, Hypoglycemia, Hypoglycemia counterregulation
Plan
| Disclosures: Dr Alsahli has nothing to disclose. |
|
| Funding Sources: Dr Gerich: University of Rochester Senior Faculty Associates Program. |
|
| Conflict of Interest: Dr Gerich: Consultant: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi-Aventis, and Janssen Pharmaceuticals. |
|
| Speakers' Bureau: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi-Aventis, and Janssen Pharmaceuticals. |
© 2013
Elsevier Inc. Tous droits réservés.
Vol 42 - N° 4
P. 657-676 - décembre 2013 Retour au numéro
Article précédent
- Why Focus on Complications?
- Emilia Pauline Liao, Leonid Poretsky
- Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
- Jelena Maletkovic, Andrew Drexler
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?